Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Application of Ketamine for Sedation in Patients With Cardiac Arrest: Feasibility, Safety, and Potential Impact on Neurological Outcomes

NCT04360070 is registered in ClinicalTrials.gov with Fraser Health as lead sponsor.

NCT NCT04360070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04360070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Application of Ketamine for Sedation in Patients With Cardiac Arrest: Feasibility, Safety, and Potential Impact on Neurological Outcomes
Lead sponsor
Fraser Health
Phase
Not applicable
Overall status
Unknown status
Start date
February 28, 2022
Completion date
December 12, 2023
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac arrest, out-of-hospital, ketamine, neurologic manifestations